Giménez, N., Schulz, R., Higashi, M., Aymerich, M., Villamor, N., Delgado, J., . . . Colomer, D. (2020). Targeting IRAK4 disrupts inflammatory pathways and delays tumor development in chronic lymphocytic leukemia. Leukemia, 34(1), . https://doi.org/10.1038/s41375-019-0507-8
Chicago Style (17th ed.) CitationGiménez, Neus, et al. "Targeting IRAK4 Disrupts Inflammatory Pathways and Delays Tumor Development in Chronic Lymphocytic Leukemia." Leukemia 34, no. 1 (2020). https://doi.org/10.1038/s41375-019-0507-8.
MLA (9th ed.) CitationGiménez, Neus, et al. "Targeting IRAK4 Disrupts Inflammatory Pathways and Delays Tumor Development in Chronic Lymphocytic Leukemia." Leukemia, vol. 34, no. 1, 2020, https://doi.org/10.1038/s41375-019-0507-8.
Warning: These citations may not always be 100% accurate.